Stock Events

Stock Events

Search...

Summit Therapeutics (SMMT) Q2 2023 Earnings

9AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-1.43

-0.96

-0.49

-0.02

Details

Expected EPS

N/A

Actual EPS

-0.02

Surprise EPS

-0.02

Surprise Percent

+∞%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.02 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.